Tricida, Inc.
Pharmaceutical ManufacturingView the employees at
Tricida, Inc.-
Jun Shao Director, Medical Affairs & Biology at Tricida, Inc.
-
Santa Clara, California, United States
-
Rising Star
Strever Seegmiller Associate Director of Drug Product Manufacturing at Tricida, Inc.-
South San Francisco, California, United States
-
Rising Star
Vinaya Kapoor Regulatory, CMC and Program Management-
Rising Star
Robert Fittro Senior Director - Head of Drug Safety & Pharmacovigilance-
Longmont, Colorado, United States
-
Rising Star
Norbert Binik Senior IT Systems Engineer at Tricida, Inc.-
Cupertino, California, United States
-
Rising Star
Overview
Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density. Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.
-